George Lawrence Mikan III - Mar 7, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
CEO & President, Director
Signature
/s/ Eric Halverson for George Lawrence Mikan III, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
Mar 7, 2024
Transactions value $
-$120,822
Form type
4
Date filed
3/11/2024, 09:22 PM
Previous filing
Mar 8, 2024
Next filing
Mar 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +7.57K +8.52% 96.4K Mar 7, 2024 Direct F1
transaction NEUE Common Stock Sale -$77.9K -7.89K -8.18% $9.88* 88.5K Mar 7, 2024 Direct F2, F3
transaction NEUE Common Stock Sale -$42.9K -5.1K -5.76% $8.42* 83.4K Mar 8, 2024 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -7.57K -50% $0.00 7.57K Mar 7, 2024 Common Stock 7.57K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.32 to $11.05 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $9.30 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 These restricted stock units vest in three equal annual installments beginning on March 7, 2023.